2. ONE MORE, I have often heard that the profit ‘margin’ is given prime consideration over uiversal drug benefits. I hear the same argument within the petroleum industry. Can you refer me to some reliable info about this subject?
Profit margin, from where the investment firms stand, is always given the
ONLY consideration. We don't necessarily try to invest in the well-being of mankind, we are trying to invest in what makes the most sense for our investors. The moment when we start to care more for the universal benefits of people as a whole is the moment we would instead turn ourselves into a nonprofit organization handling charitable-like investments. How we are respected by people in general is through the hands of highly capable public relations firms that make what we do invest into relevant to the average man.
Within the United States universal drug benefits, at least the way we see it, refers to the socialistic type programs like that of Medicare and/or Medicaid. From what I've gathered, my firm as well as many others subscribe to the view that universal entitlement programs, based on age or poverty level, provided by seniors' drug-benefit programs is unnecessary and inefficient relative to more limited policy options, and is unfair to the rest of the population. Furthermore, such policies also lead to unsustainable demand by consumers for pharmaceuticals that, in turn, provokes governments to adopt cost-control policies that reduce consumer choice, stifle pharmaceutical innovation and, by extension, harm the health of patients.
There is a good economist by the name of Brett Skinner, who works for the Fraser institute, whom for years has preached the common sermon that all investment firms and many economists alike have with regards to universal drug benefits and their overall toll on both profit margin and industry growth.
Here is a basic article (
Below) he wrote that we often reference in order to describe our stance. Remember, we are in the business of making money, not sharing it..
http://www.fraserinstitute.org/research-news/display.aspx?id=13568"
1"